Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2025-04-01
DOI
https://doi.org/10.1016/j.eclinm.2025.103184
Citations
5
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
10.03
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial

Sen Wei, Shaohan Yin, Yi Hu, ShiYang Zheng et al.
5 citations
EClinicalMedicine
Esophageal Cancer Research and Treatment
10.03
article

Safety and efficacy of neoadjuvant toripalimab plus chemotherapy followed by chemoradiotherapy for locally advanced esophageal squamous cell carcinoma in China (GASTO 1071): a non-randomised, two-cohort, phase 2 trial

Sen Wei, Shaohan Yin, Yi Hu, ShiYang Zheng, YuMing Rong, FangJie Liu, Chuanmiao Xie, Bo Qiu, Y. Situ, PengXin Zhang, Mengru Wang, DaQuan Wang, Hao Zhang, Hui Liu
article en
5 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 82
Sun Yat-sen University (CN), Gansu Provincial Hospital (CN), Sun Yat-sen University Cancer Center (CN)
Good health and well-being
Openalex Percentile: Top 2%
Esophageal Cancer Research and Treatment
10.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.